Roche And Biogen Settle Patent Row Over Arthritis Biosimilar
By Henrik Nilsson · October 23, 2023, 11:12 PM EDT
Pharmaceutical company Hoffmann-La Roche Inc. has settled a patent lawsuit alleging that Biogen MA Inc.'s proposed similar version of Roche's rheumatoid arthritis drug Actemra infringed several patents, according to a joint stipulation...
To view the full article, register now.